Short Interest in Akanda Corp. (NASDAQ:AKAN) Declines By 87.0%

Akanda Corp. (NASDAQ:AKANGet Free Report) was the target of a significant drop in short interest in June. As of June 30th, there was short interest totaling 18,178 shares, a drop of 87.0% from the June 15th total of 139,841 shares. Based on an average daily trading volume, of 44,335 shares, the days-to-cover ratio is presently 0.4 days. Currently, 4.2% of the shares of the company are sold short.

Akanda Trading Down 1.1%

AKAN traded down $0.11 during midday trading on Friday, hitting $9.94. The company had a trading volume of 16,114 shares, compared to its average volume of 309,926. Akanda has a twelve month low of $2.30 and a twelve month high of $209.02. The firm’s 50-day simple moving average is $19.04 and its 200-day simple moving average is $10.71.

Akanda (NASDAQ:AKANGet Free Report) last posted its quarterly earnings data on Tuesday, June 9th. The company reported ($317.90) earnings per share for the quarter.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Weiss Ratings lowered shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, May 18th. Wall Street Zen raised shares of Akanda to a “sell” rating in a report on Saturday, May 30th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Akanda currently has a consensus rating of “Sell”.

View Our Latest Research Report on Akanda

Akanda Company Profile

(Get Free Report)

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

See Also

Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.